Publications

epiforecasts/covid.german.forecasts.

BOSSE, N; ABBOTT, S; FUNK, S;

2022

, Github (2022).

Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study.

Li, X; HODGSON, D; Flaig, J; Kieffer, A; Herring, WL; Beyhaghi, H; Willem, L; JIT, M; Bilcke, J; Beutels, P; REspiratory Syncytial virus Consortium in EUrope (,;

2022

Value in health, (2022).26 4 10.1016/j.jval.2022.11.014.

Evaluating the impact of Respiratory Syncytial Virus immunisation strategies on antibiotic use and drug resistant bacterial infections in England.

ATKINS, KE; Hodgson, D; Jit, M; DAVIES, NG;

2022

Wellcome Open Research, (2022).7, 10.12688/wellcomeopenres.18183.1.

A Shiny App to predict subnational COVID-19 outbreak risk in EU countries.

ROBERT, A; Chapman, L; FUNK, S; Kucharski, A;

2022

(2022).

Variance-based sensitivity analysis of tuberculosis transmission models.

SUMNER, T; WHITE, RG;

2022

Journal of the Royal Society, Interface, (2022).19 196 10.1098/rsif.2022.0413.

Modelling Crimean-Congo haemorrhagic fever virus transmission: epidemiological insights and vaccine efficacy from different settings.

VESGA GAVIRIA, J; Clark, M; Ayazi, E; Apolloni, A; Leslie, T; Msimang, V; Thompson, PN; EDMUNDS, J; Metras, R;

2022

(2022).

Adam Kucharski's Invited Discussion Contribution to the Papers in Session 3 of The Royal Statistical Society's Special Topic Meeting on Covid-19 Transmission: 11 June 2021.

KUCHARSKI, A;

2022

Journal of the Royal Statistical Society Series A: Statistics in Society, (2022).185 Supplement_1 10.1111/rssa.12978.

Sebastian Funk, Sam Abbott and Johannes Bracher's Discussion Contribution to the Papers in Session 2 of The Royal Statistical Society's Special Topic Meeting on Covid-19 Transmission: 11 June 2021.

FUNK, S; ABBOTT, S; Bracher, J;

2022

Journal of the Royal Statistical Society Series A: Statistics in Society, (2022).185 Supple 10.1111/rssa.12974.

Global spatiotemporal trends and determinants of COVID-19 vaccine acceptance on Twitter: a multilingual deep learning study in 135 countries and territories.

Zhou, X; Zhang, X; Larson, H; De Figueiredo, A; JIT, M; Fodeh, S; Vermund, S; Zang, S; Lin, L; Hou, Z;

2022

medRxiv (2022). 10.1101/2022.11.14.22282300.

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.

ZHENG, B; Green, AC A; TAZARE, J; Curtis, HJ; Fisher, L; Nab, L; SCHULTZE, A; MAHALINGASIVAM, V; PARKER, EP K; Hulme, WJ; Bacon, SC J; DeVito, NJ; Bates, C; Evans, D; Inglesby, P; Drysdale, H; Davy, S; Cockburn, J; Morton, CE; Hickman, G; Ward, T; Smith, RM; Parry, J; Hester, F; Harper, S; ... TOMLINSON, LA.

2022

BMJ (Clinical research ed.), (2022).379, 10.1136/bmj-2022-071932.